Invitation to a Round Table Discussion on Public-Private Partnerships and Collaborations with US FDA at LifeSci Village to Advance BioMedical Innovation: October 26th-27th 2015

Global Business Inroads (GBI), Bangalore, India in cooperation with Global LifeSci Development Corporation (GLDC), Maryland, USA is assisting highly innovative technology companies from around the world internationalize by providing them the eco-system needed for entities to be successful and sustainable in the US and Global markets.

GLDC in collaboration with the U. S. Food and Drug Administration (FDA) and Montgomery County, Maryland, USA is developing a Public-Private Partnership to setup a $3 Billion  biomedical cluster called the  LifeSci Village™ which will be the international ‘Port-of-Entry’ into the U.S. Public Health Market; it is planned to be a 300-acre, mixed-use, international epicenter for advancing global health and biomedical innovations in a mixed-use community setting, including a biomedical consortium campus for up to 16 world-renowned universities, researchers, patient advocacy groups, health professionals and foundations (known as “The IV2 Alliance™”); private biomedical and biotechnology enterprises; hotel and conference center; quality restaurants, shops, residences, entertainment venues, and public parks and spaces. The FDA’s Office of Regulatory Affairs will also be headquartered within this cluster.

The IV2 Alliance™ and the US FDA have already entered into a Memorandum of Understanding to collaborate and advance the US FDA's global health initiatives, including the US FDA’s “Driving Biomedical Innovation” initiative.  LifeSci Village™ and The IV2 Alliance™ are being designed to offer meaningful value to all stakeholders who co-locate at LifeSci Village™ --- not only to help the US FDA fulfill its global health mission; but also, as an attractive and vibrant bioscience epicenter for collaborations and opportunities to form unique business relationships among private global health enterprises and public health organizations world-wide.

GLDC has opened up the LifeSci Village™ for Indian and European biomedical research and/or academic and/or private enterprises looking to locate themselves in the US within this cluster. They would also like to invite representatives from these entities on Monday, October 26, 2015 & Tuesday, October 27, 2015 to an exclusive “By Invitation Only” Roundtable event in White Oak, Maryland, USA to discuss Public-Private Partnerships and Collaborations with US FDA at LifeSci Village™ and with The IV2 Alliance™ in White Oak, Maryland (adjoining the US FDA Headquarters) to Advance BioMedical Innovation.

Some of the participants on the panel will include key representatives from:

  • U.S. Food and Drug Administration
  • Maryland’s U.S. Congressional Delegation
  • State of Maryland
  • Montgomery County, Maryland
  • United Therapeutics Corporation
  • Global Business Inroads (India)
  • Global LifeSci Development Corporation/The IV2 Alliance, Inc.

This two-day event will provide various prospective stakeholders the opportunity to have a voice in custom-designing the proposed set of programs and the physical attributes of the planned LifeSci Village™, so that LifeSci Village™ can be designed and constructed to represent a most beneficial “value add” proposition for the various stakeholders.  

Please note this is a By Invitation Only”/Very Limited Seating/First Come-First Served Roundtable Discussion Event send us an email to [email protected] to know more about this great opportunity and to attend the round table event in October 2015. We will be happy to connect with and setup a discussion with our colleagues at GLDC.